Calcipotriol plus betamethasone dipropionate aerosol foam vs. apremilast, methotrexate, acitretin or fumaric acid esters for the treatment of plaque psoriasis: a matching‐adjusted indirect comparison

Background Plaque psoriasis has significant impact on patients’ quality of life. Topical therapy is considered the treatment mainstay for mild‐to‐moderate disease according to guidelines. Calcipotriol/betamethasone dipropionate (Cal/BD) [0.005%/0.05%] aerosol foam is indicated for psoriasis vulgaris...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the European Academy of Dermatology and Venereology 2019-06, Vol.33 (6), p.1107-1115
Hauptverfasser:	Bewley, A.P., Shear, N.H., Calzavara‐Pinton, P.G., Hansen, J.B., Nyeland, M.E., Signorovitch, J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Acitretin - administration & dosage Acitretin - therapeutic use Administration, Cutaneous Aerosols Betamethasone - administration & dosage Betamethasone - analogs & derivatives Betamethasone - therapeutic use Calcitriol - administration & dosage Calcitriol - analogs & derivatives Calcitriol - therapeutic use Dermatologic Agents - administration & dosage Dermatologic Agents - therapeutic use Drug Therapy, Combination Esters Female Fumarates - administration & dosage Fumarates - therapeutic use Humans Male Methotrexate - administration & dosage Methotrexate - therapeutic use Middle Aged Original Psoriasis Psoriasis - drug therapy Thalidomide - administration & dosage Thalidomide - analogs & derivatives Thalidomide - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!